RPN1 (ribonucleoprotein I), a key regulator of membrane-bound glycosylation, is abnormally highly expressed in TNBC.RPN1 enhances the stability of PD-L1 by promoting its glycosylation modification, which mediates tumor cell immune escape. The gene discussed is CD274; the disease is neoplasm.